CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition 10% owner disposed of 535,000 shares (other)
- 3 Insider Initial Statement of Ownership
- 4 Other disposition See Explanation of Responses disposed of 5,680,000 shares (other)
- 4 Planned sale Chief Legal Officer sold 500 shares at $16.33 ($8,165)
- 4 Planned sale Chief Legal Officer sold 500 shares at $15.00 ($7,500)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Legal Officer sold 1,750 shares at $27.11 ($47,443)
- 4 Planned sale Chief Legal Officer sold 1,996 shares at $25.00 ($49,900)
- 4 Planned sale Chief Executive Officer sold 12,923 shares at $22.49 ($290,598)
- 4 Planned sale Chief Legal Officer sold 4,248 shares at $21.36 ($90,758)
Page 3 of 9 · 170 filings